Top Markets
#1 Threshold Network Threshold Network +63.57%
#2 TENDIES TENDIES +56.27%
#3 Cash Cat Cash Cat +19.11%
#4 OSK OSK +15.52%
#5 Ape and Pepe Ape and Pepe +12.62%
#6 Magma Finance Magma Finance +11.91%
#7 龙虾 (Lobster) 龙虾 (Lobster) +11.33%
#8 Falcon Finance Falcon Finance +11.16%
#9 Safe Safe +9.82%
#10 Asteroid Shiba Asteroid Shiba +9.40%
Coin of the day
Threshold Network Threshold Network
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Classifica tra le azioni #17187
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Prezzo delle azioni
$2.20
Ultima sincronizzazione: 2026-09-01
Capitalizzazione di mercato
$253.81M
Variazione (1 giorno)
10.29%
Variazione (1 anno)
99.67%
Paese
CA
Scambia Cardiol Therapeutics Inc. (CRDL)

Categoria

Healthcare
Il prezzo CRDL con la capitalizzazione del mercato della B
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
CRDL
$2.20
Capitalizzazione di mercato di Cardiol Therapeutics Inc.(CRDL)
Capitalizzazione di mercato: $253.81M
A partire dal September 2026, Cardiol Therapeutics Inc. ha una capitalizzazione di mercato pari a $253.81M. Questo rende Cardiol Therapeutics Inc. la 17187th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Cardiol Therapeutics Inc. dal 2018 al 2026
CRDL in paragone con la classifica dei più popolari stocks
Il prezzo per CRDL Attivo B Capitalizzazione del mercato a B Risultati
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$45,627.72 $253.81M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.260T +2,072,181.83%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$41,454.31 $253.81M
Apple Inc. Apple Inc.
AAPL
$4.779T +1,882,637.41%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$34,845.69 $253.81M
Alphabet Inc. Alphabet Inc.
GOOG
$4.017T +1,582,492.63%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$32,265.44 $253.81M
Microsoft Corporation Microsoft Corporation
MSFT
$3.719T +1,465,304.86%
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.
$23,719.85 $253.81M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.734T +1,077,188.17%